Lovenox Related Clinical Trials
Safety Evaluation of Use Sodic Enoxaparin [Completed]
Comparison of Anti-Xa Activity of ENOXA � Versus LOVENOX � in Acute Coronary Syndrome [Recruiting]
Enoxaparin Thromboprophylaxis in Cancer Patients With Elevated Tissue Factor Bearing Microparticles [Recruiting]
A Pilot Study Comparing Enoxaparin to Fondaparinux to Prevent Venous Thromboembolism (VTE) in Bariatric Surgical Patients [Recruiting]
Dose Adjusting Enoxaparin Thromboprophylaxis Dosage According to Anti-factor Xa Plasma Levels Improve Pregnancy Outcome [Recruiting]
Once Daily Enoxaparin for Outpatient Treatment of Acute DVT and/or Pulmonary Embolism [Active, not recruiting]
Taxotere-Enoxaparin-(ENOXA)-Study [Recruiting]
Enoxaparin in Children With Asymptomatic Venous Thrombosis After Pediatric Cardiac Surgery [Recruiting]
Adjusted Value of Thromboprophylaxis in Hospitalized Obese Patients: A Comparative Study of Two Regimens of Enoxaparin [Recruiting]
Comparison of Subcutaneous Heparin and Enoxaparin for Deep Venous Thrombosis (DVT) Prophylaxis in Surgical Intensive Care Patients [Recruiting]
Enoxaparin Versus Aspirin in Patients With Cancer and Stroke [Recruiting]
Comparison of Arixtra vs. Lovenox to Prevent Blood Clots in Medically Ill Patients [Recruiting]
Delayed Versus Early Enoxaparin Prophylaxis After Traumatic Brain Injury (TBI) [Recruiting]
STEMI Treated With Primary Angioplasty and Intravenous Lovenox or Unfractionated Heparin (UFH) [Recruiting]
Study to Evaluate Weight-Based Enoxaparin Dosing in Obese Medical Patients at Risk for DVT [Completed]
Venous Thromboembolic Prophylaxis After Major Trauma: A Trial of Three Times a Day Unfractionated Heparin Versus Twice a Day Enoxaparin [Recruiting]
LV Thrombus Pilot Study for Comparing Enoxaparin Vs. Warfarin [Completed]
Comparison of 2 Low Molecular Heparin as a Thromboprophylaxis Postpartum [Recruiting]
A Study of Standard Treatment +/- Enoxaparin in Small Cell Lung Cancer [Recruiting]
The Effect of Vasopressors on the Anti Xa Response to Enoxaparin in Critically Ill Patients [Recruiting]
The Effect of Reduced Dose of Enoxaparin on the Outcomes of Treatment With Enoxaparin [Recruiting]
Enoxaparin Low Molecular Weight Heparin (LMWH) in Advanced Non Small Cell Lung Cancer: Effect on Survival and Symptom Control in Patients Undergoing First Line Chemotherapy (SYRINGES) [Recruiting]
The Effect of Enoxaparin Sodium on the Incidence of Deep Vein Thrombosis Following Electrophysiology Studies and Radiofrequency Ablation. [Recruiting]
Preventive Effect of Enoxaparin, Pentoxifylline and Ursodeoxycholic Acid to Radiation Induced Liver Toxicity [Recruiting]
Aspirin and Compression Devices for VTE Prophylaxis in Orthopaedic Oncology [Recruiting]
The STREAM Percutaneous Coronary Intervention Anticoagulant Sub-study [Recruiting]
Chemotherapy With or Without Enoxaparin in Pancreatic Cancer [Recruiting]
Enoxaparin and/or Minocycline in Acute Stroke [Not yet recruiting]
Prevention of Unexplained Recurrent Abortion by Enoxaparine [Recruiting]
Clot Dissolving Treatment for Blood Clots in the Lungs [Recruiting]
Enoxaparin as Treatment for Vulvodynia [Recruiting]
New Oral Anticoagulant Therapy for the Prevention of Blood Clots Following Hip or Knee Replacement Surgery [Completed]
Enoxaparin in Acute Venous Thromboembolic Disease [Active, not recruiting]
Prophylactic Enoxaparin Dosing for Prevention of Venous Thromboembolism in Pregnancy - a Prospective Randomized Trial [Recruiting]
Study to Evaluate the Mortality Reduction of Enoxaparin in Hospitalized Acutely Ill Medical Receiving Enoxaparin [Recruiting]
Adaptation Dose of Enoxaparin in Moderate Renal Failure Patients With Acute Coronary Syndrome. [Not yet recruiting]
Enoxaparin Versus Unfractionated Heparin in PCI [Completed]
Study of Apixaban for the Prevention of Thrombosis-Related Events Following Knee Replacement Surgery [Active, not recruiting]
Japanese Safety and Efficacy Study of Enoxaparin in Patients With Hip Fracture Surgery [Completed]
Ischemia Driven Enoxaparin Therapy in ACS Presenting as Low Risk (IDEAL) [Recruiting]
Anticoagulation Post Laparoscopic Splenectomy [Recruiting]
Assessment of Cardioversion Using Transesophageal Echocardiography II (ACUTE II) [Completed]
Docetaxel and Liposomal Doxorubicin Chemotherapy With Enoxaparin in Patients With Advanced Pancreatic Cancer [Recruiting]
Identification and Treatment of Clinically Silent Catheter-Related Deep Vein Thrombosis in Children With Cancer [Recruiting]
PREVAIL: PREvention of VTE After Acute Ischemic Stroke With LMWH Enoxaparin ( - VTE: Venous Thromboembolism - LMWH: Low Molecular Weight Heparin) [Completed]
Bioavailability Study of Enoxaparin Sodium Chemi and Clexane s.c. [Recruiting]
Adjuvant Treatment of Pulmonary Embolism With Drotrecogin Alfa (Activated): Phase II Exploratory Study [Completed]
Study of an Investigational Drug for the Prevention of Thrombosis-Related Events Following Knee Replacement Surgery [Recruiting]
HENOX: Enoxaparine in Hemodialysis [Completed]
Total Hip Replacement Study With XRP4563 (Enoxaparin Sodium) [Completed]
Once Weekly Subcutaneous Ports for the Administration of Enoxaparin [Recruiting]
Enoxaparin Versus Unfractionated Heparin in Subjects Who Present to the Emergency Department With Acute Coronary Syndrome (RESCUE) [Completed]
Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment Thrombolysis in Myocardial Infarction - Study 25 (ExTRACT-TIMI25) [Completed]
Safety and Efficacy of Enoxaparin in Percutaneous Coronary Intervention (PCI) Patients, an International Randomized Evaluation (STEEPLE) [Completed]
RE-MODEL Dabigatran Etexilate 150mg or 220mg o.d vs. Enoxaparin 40mg o.d for Prevention of Thrombosis After Knee Surgery [Completed]
Prevention of Venous Thromboembolism in Patients With Acute Primary Intracerebral Hemorrhage [Recruiting]
Efficacy of the Association Mechanical Prophylaxis + Enoxaparin on Venous Thromboembolism Incidence in Intensive Care Unit (ICU) [Recruiting]
Study of an Investigational Drug for the Prevention of Thrombosis-Related Events Following Hip Replacement Surgery [Recruiting]
Thrombelastography Based Dosing of Enoxaparin [Recruiting]
Evaluation of AVE5026 as Compared to Enoxaparin for the Prevention of Thromboembolism in Patients Undergoing Hip Fracture Surgery [Recruiting]
Evaluation of AVE5026 as Compared to Enoxaparin for the Prevention of Thromboembolism in Patients Undergoing Elective Knee Replacement Surgery [Recruiting]
Evaluation of AVE5026 as Compared to Enoxaparin for the Prevention of Thromboembolism in Patients Undergoing Total Hip Replacement Surgery [Recruiting]
Evaluation of AVE5026 as Compared to Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Major Abdominal Surgery [Recruiting]
Dabigatran Etexilate Compared With Enoxaparin in Prevention of VTE Following Total Hip Arthroplasty [Recruiting]
Heparin or Enoxaparin in Patients With Cancer [Completed]
Pharmacodynamics Study of Enoxalow Compared to Clexane in Healthy Subjects After Subcutaneous Single Dose [Not yet recruiting]
Pharmacodynamics Study of Enoxalow Compared to Clexane in Healthy Subjects After Intravenous Administration [Not yet recruiting]
Prophylactic Use of Sodium Enoxaparin for Venous Thromboembolism in High-Risk Abdominal Surgery [Not yet recruiting]
Evaluation of Pre-Dose and Post-Dose Anti-Factor Xa Levels With Enoxaparin Use During Pregnancy [Completed]
Etude (Study) Phase I Enox - UnFractionated Heparin (UFH) [Completed]
ARIXTRA Local Study For Registration In China. [Completed]
A Study to Evaluate Efficacy and Safety of TAK-442 in Subjects Undergoing Total Knee Replacement [Recruiting]
Prevention of Maternal and Perinatal Complications by Enoxaparin in Women With Previous Severe Preeclampsia [Recruiting]
Evaluation of AVE5026 in the Prevention of Venous Thromboembolism in Acutely Ill Medical Patients With Restricted Mobility [Recruiting]
Low Molecular Weight Heparin vs Unfractionated Heparin at Cardiac Surgery [Completed]
EXCLAIM:Extended Prophylaxis for Venous ThromboEmbolism (VTE) in Acutely Ill Medical Patients With Prolonged Immobilization [Completed]
Patients With High-risk Acute Coronary Syndrome Without ST-segment Elevation [Recruiting]
Factor Xa Inhibitor, PRT054021, Against Enoxaparin for the Prevention of Venous Thromboembolic Events (EXPERT) [Completed]
Melagatran/Ximelagatran Versus Enoxaparin for the Prevention of Venous Thromboembolic Events [Terminated]
Michelangelo – Oasis 5 [Completed]
SYNERGY: Open Study of Enoxaparin vs. Unfractionated Heparin in Patients With Acute Coronary Syndromes [Completed]
Regulation of Coagulation in Orthopedic Surgery to Prevent DVT and PE; a Controlled, Double-Blind, Randomized Study of BAY 59-7939 in the Prevention of VTE in Subjects Undergoing Elective Total Knee Replacement (RECORD 4) [Completed]
Thromboprophylaxis and Bariatric Surgery [Recruiting]
The Use of Low Molecular Weight Heparin in Traumatic Brain Injury
Factor Xa Inhibitor for Prevention of Venous Thromboembolism in Patients Undergoing Elective Total Knee Replacement [Recruiting]
Overall Survival of Inoperable Gastric/GastroOesophageal Cancer Subjects on Treating With LMWH + Chemotherapy(CT) Versus Standard CT [Recruiting]
Efficacy of Bemiparin Versus Enoxaparin in the Treatment of DVT [Recruiting]
Evaluation of PD 0348292 for Preventing Blood Clots in the Lungs or Deep Leg Veins of Patients After Knee Surgery
ABRIDGE: Low Molecular Weight Heparin in Bridging Patients After Mechanical Valve Replacement
Dabigatran Etexilate in Extended VTE Prevention After Hip Replacement Surgery
Efficacy and Safety of the LovenoxTM (Enoxaparin) Versus HeparinTM Gynecologic Oncology Patients [Recruiting]
Phase I Study to Assess Safety and Pharmacokinetics of GMI-1271 in Healthy Adult Subjects [Recruiting]
Patients Preference With Self-Injection: The PRISM Study [Recruiting]
Study of the Efficacy, Safety and Tolerability of Low Molecular Weight Heparin vs. Unfractionated Heparin in Stroke [Recruiting]
BMS-562247 in Subjects Undergoing Elective Total Knee Replacement Surgery [Completed]
Echo-Doppler Assessment of the Occurrence of Asymptomatic DVT in Orthopedic Replacement Surgery Under Enoxaparin [Recruiting]
Dabigatran Etexilate vs Enoxaparin in Prevention of VTE Post Total Knee Replacement [Completed]
Comparison of Angiomax Versus Heparin in Acute Coronary Syndromes (ACS) [Completed]
Comparing Anti-XA Levels in Post-Cesarean Patients Undergoing Enoxaparin Thromboprophylaxis [Recruiting]
Which Therapy for Acute Heart Attacks? (The WEST Study) [Completed]
An Oral, Direct Factor Xa Inhibitor, BAY 59-7939, for Prophylaxis Against Venous Thromboembolism After Total Knee Replacement: a Dose-Ranging Study [Completed]
|
